Biomotion Sciences Ordinary Shares
Price & Volume
Stats
See more52W Range | $0.20-$13.55 |
Market Cap | $9.8M |
Shares Short | 375,527 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.66 |
News
See moreYahoo Finance • 14 days ago
Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data
Yahoo Finance • 24 days ago
Silexion Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
Yahoo Finance • 2 months ago
Silexion Therapeutics Announces Exercise of Warrants for $3.3 Million Gross Proceeds
About
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
